approval
saveILUMYA (TILDRAKIZUMAB-ASMN) — FDA approval
December 12, 2025updated 5mo ago
community read0 votes
Sponsor: SUN PHARMA GLOBAL. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 6
- approvalBUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE: SYNALGOS-DC (ASPIRIN) — FDA approvalDec 22, 2025
- approvalMETHADONE HYDROCHLORIDE: METHADONE HYDROCHLORIDE — FDA approvalDec 22, 2025
- approvalMETHADONE HYDROCHLORIDE: METHADONE HYDROCHLORIDE — FDA approvalDec 22, 2025
- approvalMEPERIDINE HYDROCHLORIDE: MEPERIDINE HYDROCHLORIDE — FDA approvalDec 22, 2025
- approvaltramadol hydrochloride ER: TRAMADOL HYDROCHLORIDE — FDA approvalDec 29, 2025
- recallFARMAKEIO OUTSOURCING LLC recall (Cls II)Nov 5, 2025
🐶 often sniffed alongside
top 8- drugARYNTA31 co-mentions · 10 sources
- drugLISDEXAMFETAMINE DIMESYLATE31 co-mentions · 10 sources
- tagRecall30 co-mentions · 16 sources
- companyOhm Laboratories Inc17 co-mentions · 9 sources
- drugGralise6 co-mentions · 2 sources
- drugNeurontin6 co-mentions · 2 sources
- drugGABAPENTIN6 co-mentions · 2 sources
- tagDrug Shortage4 co-mentions · 4 sources
comments(0)
5-min edit window · permanent after that